DZ Bank’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $24.2M | Buy |
38,792
+522
| +1% | +$355K | 0.02% | 261 |
|
|
2026
Q1 | $29.6M | Sell |
38,270
-168
| -0.4% | -$129K | 0.03% | 221 |
|
|
2025
Q4 | $29.7M | Buy |
38,438
+2,026
| +6% | +$1.38M | 0.03% | 226 |
|
|
2025
Q3 | $20.5M | Sell |
36,412
-3,257
| -8% | -$1.84M | 0.02% | 270 |
|
|
2025
Q2 | $20.8M | Buy |
39,669
+1,625
| +4% | +$907K | 0.02% | 265 |
|
|
2025
Q1 | $24.1M | Buy |
38,044
+27,482
| +260% | +$18.9M | 0.03% | 230 |
|
|
2024
Q4 | $7.52M | Sell |
10,562
-30,769
| -74% | -$25.8M | 0.01% | 364 |
|
|
2024
Q3 | $43.4M | Sell |
41,331
-4,718
| -10% | -$5.25M | 0.04% | 182 |
|
|
2024
Q2 | $48.4M | Sell |
46,049
-3,377
| -7% | -$3.27M | 0.05% | 164 |
|
|
2024
Q1 | $47.6M | Buy |
49,426
+2,043
| +4% | +$1.94M | 0.05% | 172 |
|
|
2023
Q4 | $41.6M | Sell |
47,383
-336
| -0.7% | -$277K | 0.05% | 182 |
|
|
2023
Q3 | $39.3M | Sell |
47,719
-4,983
| -9% | -$3.92M | 0.06% | 175 |
|
|
2023
Q2 | $37.9M | Buy |
52,702
+12,316
| +30% | +$9.5M | 0.06% | 180 |
|
|
2023
Q1 | $33.2M | Buy |
40,386
+10,143
| +34% | +$7.65M | 0.05% | 199 |
|
|
2022
Q4 | $21.8M | Buy |
30,243
+1,926
| +7% | +$1.42M | 0.04% | 238 |
|
|
2022
Q3 | $19.5M | Buy |
28,317
+19,419
| +218% | +$12.2M | 0.04% | 222 |
|
|
2022
Q2 | $5.26M | Buy |
8,898
+2,825
| +47% | +$1.84M | 0.01% | 428 |
|
|
2022
Q1 | $4.24M | Sell |
6,073
-78,165
| -93% | -$49.5M | 0.01% | 524 |
|
|
2021
Q4 | $53.7M | Buy |
84,238
+14,120
| +20% | +$8.68M | 0.04% | 231 |
|
|
2021
Q3 | $42.4M | Buy |
70,118
+29,908
| +74% | +$18.6M | 0.07% | 172 |
|
|
2021
Q2 | $22.5M | Buy |
40,210
+2,096
| +5% | +$1.06M | 0.04% | 259 |
|
|
2021
Q1 | $18M | Buy |
38,114
+8,917
| +31% | +$4.34M | 0.03% | 266 |
|
|
2020
Q4 | $14.1M | Sell |
29,197
-7,047
| -19% | -$3.8M | 0.03% | 283 |
|
|
2020
Q3 | $20.3M | Sell |
36,244
-1,711
| -5% | -$1.04M | 0.05% | 208 |
|
|
2020
Q2 | $23.7M | Sell |
37,955
-2,953
| -7% | -$1.68M | 0.06% | 175 |
|
|
2020
Q1 | $20M | Sell |
40,908
-14,276
| -26% | -$5.89M | 0.07% | 164 |
|
|
2019
Q4 | $20.7M | Sell |
55,184
-7,498
| -12% | -$2.52M | 0.05% | 186 |
|
|
2019
Q3 | $17.4M | Buy |
62,682
+5,035
| +9% | +$1.49M | 0.05% | 198 |
|
|
2019
Q2 | $18M | Buy |
57,647
+26,113
| +83% | +$8.69M | 0.06% | 197 |
|
|
2019
Q1 | $12.9M | Buy |
31,534
+8,287
| +36% | +$3.41M | 0.04% | 232 |
|
|
2018
Q4 | $8.43M | Buy |
23,247
+22,237
| +2,202% | +$8.14M | 0.03% | 267 |
|
|
2018
Q3 | $408K | Buy |
+1,010
| New | +$384K | ﹤0.01% | 623 |
|
|
2018
Q2 | – | Sell |
-5,834
| Closed | -$2.01M | – | 1041 |
|
|
2018
Q1 | $2.01M | Buy |
5,834
+5,147
| +749% | +$1.79M | 0.01% | 548 |
|
|
2017
Q4 | $258K | Sell |
687
-313
| -31% | -$127K | ﹤0.01% | 701 |
|
|
2017
Q3 | $447K | Hold |
1,000
| – | – | ﹤0.01% | 656 |
|
|
2017
Q2 | $491K | Buy |
+1,000
| New | +$438K | ﹤0.01% | 636 |
|
Other funds holding REGN
DZ Bank's REGN Position: Q2 2026 in Review
DZ Bank increased its Regeneron Pharmaceuticals (REGN) stake by 1.4% in Q2 2026, buying an estimated $355K and bringing the position to 38,792 shares worth $24.2M. The position accounts for 0.02% of the portfolio, ranked #261.
DZ Bank first reported a position in REGN in Q2 2017 and has held it in 36 quarters since. The position peaked at $53.7M in Q4 2021. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- DZ Bank held 38,792 shares of Regeneron Pharmaceuticals worth $24.2M as of Q2 2026.
- DZ Bank bought 522 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $355K.
- Regeneron Pharmaceuticals made up 0.02% of DZ Bank's portfolio in Q2 2026, its #261 holding.
- DZ Bank first reported a position in Regeneron Pharmaceuticals in Q2 2017 and has held it in 36 quarters since.
- DZ Bank's Regeneron Pharmaceuticals position peaked at $53.7M in Q4 2021.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on DZ Bank's 13F filing for Q2 2026, filed 14 Aug 2026.